Overview
Pontine tegmental cap dysplasia (PTCD) is an extremely rare congenital hindbrain malformation characterized by a distinctive cap-like protuberance on the dorsal surface of the pons, visible on brain MRI. This neurodevelopmental disorder primarily affects the brainstem and cranial nerves, resulting from abnormal axonal guidance during embryonic development. The condition was first described in 2007 and affects multiple body systems due to cranial nerve dysfunction. Key clinical features include multiple cranial nerve palsies, which can manifest as hearing loss (sensorineural deafness), facial weakness, swallowing difficulties (dysphagia), and impaired eye movements. Many patients also exhibit ataxia (impaired coordination), cognitive impairment of variable severity, and structural brain anomalies beyond the pontine malformation, including cerebellar hypoplasia and absence or hypoplasia of specific cranial nerves. Additional features may include short stature, scoliosis, and cardiac or dental anomalies. Breathing and feeding difficulties may be prominent in the neonatal period. There is currently no curative treatment for pontine tegmental cap dysplasia. Management is supportive and multidisciplinary, focusing on addressing individual symptoms such as hearing aids or cochlear implants for hearing loss, speech therapy, physical therapy for motor difficulties, and nutritional support for feeding problems. Prognosis varies depending on the severity of brainstem involvement. Fewer than 40 cases have been reported in the medical literature worldwide.
Also known as:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Pontine tegmental cap dysplasia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Pontine tegmental cap dysplasia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Pontine tegmental cap dysplasia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Pontine tegmental cap dysplasia.
Community
No community posts yet. Be the first to share your experience with Pontine tegmental cap dysplasia.
Start the conversation →Latest news about Pontine tegmental cap dysplasia
No recent news articles for Pontine tegmental cap dysplasia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Pontine tegmental cap dysplasia
What is Pontine tegmental cap dysplasia?
Pontine tegmental cap dysplasia (PTCD) is an extremely rare congenital hindbrain malformation characterized by a distinctive cap-like protuberance on the dorsal surface of the pons, visible on brain MRI. This neurodevelopmental disorder primarily affects the brainstem and cranial nerves, resulting from abnormal axonal guidance during embryonic development. The condition was first described in 2007 and affects multiple body systems due to cranial nerve dysfunction. Key clinical features include multiple cranial nerve palsies, which can manifest as hearing loss (sensorineural deafness), facial
How is Pontine tegmental cap dysplasia inherited?
Pontine tegmental cap dysplasia follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Pontine tegmental cap dysplasia typically begin?
Typical onset of Pontine tegmental cap dysplasia is neonatal. Age of onset can vary across affected individuals.